A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305.
Clinical trial NCT00668837 · COMPLETED
Trial details
- NCT number
- NCT00668837
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.